Prosight Management, LP Quant / Systematic

CIK: 0001617201 · Show all filings

Period: Q1 2022 (← Previous) (Next →)

Filing Date: May 16, 2022

Total Value ($000): $154,864 (100.0% shares, 0.0% debt)

Holdings (32)

GLPG GALAPAGOS NV 15.0%
Value ($000) $23,195 Shares 374,000 Est. Cost $58.55 Unrealized
PRTA PROTHENA CORP PLC 13.4%
Value ($000) $20,718 Shares 566,538 Est. Cost $26.31 Unrealized +37.0%
ALBIREO PHARMA INC 9.2%
Value ($000) $14,318 Shares 480,000 Est. Cost $30.59 Unrealized
GALAPAGOS NV 7.8%
Value ($000) $12,094 Shares 195,000 Est. Cost Unrealized
CRL CHARLES RIV LABS INTL INC 5.8%
Value ($000) $8,945 Shares 31,500 Est. Cost $347.75 Unrealized -11.3%
KALV KALVISTA PHARMACEUTICALS INC 5.6%
Value ($000) $8,686 Shares 589,270 Est. Cost $19.16 Unrealized -25.0%
CUE CUE BIOPHARMA INC 4.8%
Value ($000) $7,370 Shares 1,510,282 Est. Cost $11.54 Unrealized -38.7%
ALDX ALDEYRA THERAPEUTICS INC 4.0%
Value ($000) $6,224 Shares 1,400,239 Est. Cost $7.18 Unrealized -44.5%
MGTX MEIRAGTX HLDGS PLC 3.4%
Value ($000) $5,273 Shares 380,700 Est. Cost $15.40 Unrealized 0.0%
KEZAR LIFE SCIENCES INC 3.2%
Value ($000) $4,986 Shares 300,000 Est. Cost $5.82 Unrealized
CONVEY HEALTH SOLUTIONS HLDG 3.2%
Value ($000) $4,893 Shares 748,134 Est. Cost $9.97 Unrealized
ALNY ALNYLAM PHARMACEUTICALS INC 2.4%
Value ($000) $3,707 Shares 22,704 Est. Cost $185.86 Unrealized -18.0%
AGL AGILON HEALTH INC 2.3%
Value ($000) $3,549 Shares 140,000 Est. Cost $31.52 Unrealized -34.6%
STTK SHATTUCK LABS INC 2.2%
Value ($000) $3,403 Shares 798,718 Est. Cost $9.93 Unrealized -42.9%
RCKT ROCKET PHARMACEUTICALS INC 2.1%
Value ($000) $3,224 Shares 203,268 Est. Cost $23.61 Unrealized -26.8%
QUIDEL CORP 1.9%
Value ($000) $2,887 Shares 25,675 Est. Cost $112.44 Unrealized
EHC ENCOMPASS HEALTH CORP 1.8%
Value ($000) $2,837 Shares 39,900 Est. Cost $49.64 Unrealized +1.2%
OSCR OSCAR HEALTH INC 1.5%
Value ($000) $2,368 Shares 237,500 Est. Cost $14.31 Unrealized -48.0%
ACCOLADE INC 1.4%
Value ($000) $2,184 Shares 124,393 Est. Cost $27.45 Unrealized
SEM SELECT MED HLDGS CORP 1.4%
Value ($000) $2,178 Shares 90,788 Est. Cost $12.31 Unrealized 0.0%
CRSP CRISPR THERAPEUTICS AG 1.4%
Value ($000) $2,134 Shares 34,000 Est. Cost $75.34 Unrealized -16.7%
INMD INMODE LTD 1.2%
Value ($000) $1,846 Shares 50,000 Est. Cost $44.79 Unrealized 0.0%
MIRM MIRUM PHARMACEUTICALS INC 1.1%
Value ($000) $1,628 Shares 73,930 Est. Cost $20.40 Unrealized 0.0%
GMED GLOBUS MED INC 0.9%
Value ($000) $1,328 Shares 18,000 Est. Cost $72.59 Unrealized -4.2%
SPRY SILVERBACK THERAPEUTICS INC 0.7%
Value ($000) $1,142 Shares 325,365 Est. Cost $4.98 Unrealized -12.5%
NEO NEOGENOMICS INC 0.5%
Value ($000) $772 Shares 63,524 Est. Cost $21.04 Unrealized 0.0%
ORGANON & CO 0.5%
Value ($000) $699 Shares 20,000 Est. Cost Unrealized
CGTX COGNITION THERAPEUTICS INC 0.4%
Value ($000) $660 Shares 240,080 Est. Cost $9.75 Unrealized -60.5%
PRQR PROQR THRAPEUTICS N V 0.3%
Value ($000) $542 Shares 599,288 Est. Cost $4.47 Unrealized -25.1%
SIO GENE THERAPIES INC 0.3%
Value ($000) $449 Shares 670,300 Est. Cost $1.98 Unrealized
IOVA IOVANCE BIOTHERAPEUTICS INC 0.2%
Value ($000) $333 Shares 20,000 Est. Cost $24.79 Unrealized -37.6%
CYMABAY THERAPEUTICS INC 0.2%
Value ($000) $292 Shares 93,923 Est. Cost $3.38 Unrealized